NASDAQ:CLLS
$1.99
(
1.02%
)
Friday, 2nd Jun 2023
Cellectis S.A. Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $1.68 | $2.00 | Friday, 2nd Jun 2023 CLLS stock ended at $1.99. This is 1.02% more than the trading day before Thursday, 1st Jun 2023. During the day the stock fluctuated 3.09% from a day low at $1.94 to a day high of $2.00. |
| 90 days | $1.68 | $2.23 | |
| 52 weeks | $1.68 | $4.10 |
Historical Cellectis S.A. prices
| Date | Open | High | Low | Close | Volume |
| 2023-06-02 | $1.99 | $2.00 | $1.94 | $1.99 | 54 798 |
| 2023-06-01 | $1.94 | $1.99 | $1.89 | $1.97 | 39 883 |
| 2023-05-31 | $1.91 | $1.91 | $1.85 | $1.90 | 58 216 |
| 2023-05-30 | $1.80 | $1.90 | $1.80 | $1.90 | 63 440 |
| 2023-05-26 | $1.82 | $1.88 | $1.80 | $1.83 | 17 068 |
| 2023-05-25 | $1.81 | $1.83 | $1.75 | $1.78 | 34 118 |
| 2023-05-24 | $1.81 | $1.81 | $1.71 | $1.72 | 45 323 |
| 2023-05-23 | $1.79 | $1.83 | $1.78 | $1.80 | 24 092 |
| 2023-05-22 | $1.74 | $1.80 | $1.71 | $1.80 | 31 805 |
| 2023-05-19 | $1.75 | $1.77 | $1.70 | $1.74 | 19 008 |
| 2023-05-18 | $1.77 | $1.79 | $1.71 | $1.77 | 64 907 |
| 2023-05-17 | $1.75 | $1.82 | $1.75 | $1.80 | 49 180 |
| 2023-05-16 | $1.70 | $1.82 | $1.69 | $1.75 | 65 528 |
| 2023-05-15 | $1.75 | $1.81 | $1.73 | $1.76 | 51 242 |
| 2023-05-12 | $1.81 | $1.82 | $1.68 | $1.74 | 207 426 |
| 2023-05-11 | $1.90 | $1.92 | $1.81 | $1.81 | 161 059 |
| 2023-05-10 | $1.84 | $1.92 | $1.84 | $1.92 | 35 452 |
| 2023-05-09 | $1.81 | $1.85 | $1.78 | $1.83 | 56 784 |
| 2023-05-08 | $1.95 | $1.95 | $1.82 | $1.90 | 166 033 |
| 2023-05-05 | $1.89 | $1.98 | $1.89 | $1.90 | 162 929 |
| 2023-05-04 | $1.92 | $1.92 | $1.86 | $1.88 | 53 003 |
| 2023-05-03 | $1.90 | $1.94 | $1.86 | $1.86 | 48 948 |
| 2023-05-02 | $1.91 | $1.92 | $1.80 | $1.83 | 33 800 |
| 2023-05-01 | $1.95 | $1.96 | $1.93 | $1.95 | 11 698 |
| 2023-04-28 | $1.88 | $1.92 | $1.88 | $1.88 | 28 475 |
| 2023-04-27 | $1.93 | $1.95 | $1.90 | $1.94 | 3 350 |
| 2023-04-26 | $1.93 | $1.93 | $1.90 | $1.91 | 7 396 |
| 2023-04-25 | $1.90 | $1.94 | $1.89 | $1.94 | 12 961 |
| 2023-04-24 | $1.89 | $1.94 | $1.89 | $1.93 | 27 193 |
| 2023-04-21 | $1.99 | $1.99 | $1.88 | $1.90 | 113 358 |
| 2023-04-20 | $1.97 | $1.99 | $1.92 | $1.92 | 45 738 |
| 2023-04-19 | $1.99 | $2.03 | $1.93 | $2.03 | 43 942 |
| 2023-04-18 | $2.04 | $2.04 | $1.97 | $2.01 | 134 020 |
| 2023-04-17 | $2.04 | $2.07 | $2.01 | $2.04 | 70 360 |
| 2023-04-14 | $2.08 | $2.14 | $2.04 | $2.04 | 46 427 |
| 2023-04-13 | $2.04 | $2.17 | $2.04 | $2.12 | 177 718 |
| 2023-04-12 | $1.99 | $2.05 | $1.99 | $2.05 | 50 324 |
| 2023-04-11 | $1.96 | $2.00 | $1.94 | $1.98 | 32 051 |
| 2023-04-10 | $1.99 | $1.99 | $1.91 | $1.96 | 14 573 |
| 2023-04-06 | $1.99 | $1.99 | $1.90 | $1.97 | 44 698 |
| 2023-04-05 | $1.92 | $1.99 | $1.91 | $1.98 | 18 051 |
| 2023-04-04 | $2.00 | $2.02 | $1.93 | $1.97 | 23 313 |
| 2023-04-03 | $1.96 | $2.02 | $1.96 | $2.01 | 32 553 |
| 2023-03-31 | $1.98 | $2.03 | $1.90 | $1.93 | 91 773 |
| 2023-03-30 | $2.01 | $2.05 | $1.96 | $2.02 | 203 462 |
| 2023-03-29 | $2.07 | $2.09 | $1.85 | $1.91 | 435 640 |
| 2023-03-28 | $2.04 | $2.06 | $2.02 | $2.04 | 6 651 |
| 2023-03-27 | $2.03 | $2.08 | $1.97 | $1.99 | 112 721 |
| 2023-03-24 | $2.02 | $2.09 | $1.98 | $2.04 | 50 253 |
| 2023-03-23 | $2.07 | $2.11 | $1.96 | $2.04 | 23 346 |
About Cellectis S.A.
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatment of CD19-expressing hematologic malignancies, such as acute lymphoblastic leukemia; ALLO-501 and ALL... CLLS Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
